中国临床药理学杂志2024，Vol.40Issue(9)：1372-1374,3.DOI:10.13699/j.cnki.1001-6821.2024.09.028
治疗早期阿尔茨海默病的潜在药物:Donanemab注射液
Potential drugs for early Alzheimer's disease:Donanemab injection
摘要
Abstract
Donanemab is a novel anti-amyloid antibody medication that is primarily used to treat early-stage symptomatic Alzheimer's disease.Clinical investigations have demonstrated that it modulates issues with cognitive function and everyday functioning.Preclinical research has discovered that it reduces amyloid deposition in the hippocampus and cortical layers of the brain.To better comprehend cutting-edge novel medications,this article examines the latest research on donanemab.关键词
阿尔茨海默病/Donanemab注射液/早期症状Key words
Alzheimer's disease/donanemab injection/early symptoms分类
医药卫生引用本文复制引用
敖日格勒宝力高,万全,白国柱,呼格吉乐巴图..治疗早期阿尔茨海默病的潜在药物:Donanemab注射液[J].中国临床药理学杂志,2024,40(9):1372-1374,3.基金项目
内蒙古自治区蒙医药标准化项目基金资助项目(2022 MB015) （2022 MB015）
